A carregar...
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in controlling HIV-1 infections, new drug ta...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
AboutScience Srl
2007-01-01
|
Colecção: | Drug Target Insights |
Acesso em linha: | https://doi.org/10.1177/117739280700200020 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|